Agitation
Information
- Disease name
- Agitation
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT01329536 | Completed | The Occurrence of the ApoE4 Allele in Agitated In-Patients With Late-Onset Alzheimer's Disease | December 2010 | October 2011 | |
NCT01517438 | Completed | N/A | Effects of Serotonin Inhibitors on Patient-controlled Analgesia Related Nausea and Vomiting | March 2011 | December 2011 |
NCT01524367 | Completed | Phase 4 | Effect of Single-dose Dexmedetomidine on Emergence Excitement in Adults With Nasotracheal Intubation After Orthognathic Surgery | October 2011 | January 2013 |
NCT01584440 | Completed | Phase 2 | Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease | August 13, 2012 | July 30, 2014 |
NCT01715506 | Completed | N/A | Continuing Education in Nursing Home Dementia Care | August 2011 | August 2015 |
NCT01747824 | Completed | Stress Biomarkers Among Patients Undergoing Treatment for Excited Delirium and Severe Pain in the Emergency Department | December 2012 | December 2015 | |
NCT01848158 | Completed | N/A | Acupuncture to Improve Comfort of Children on a Ventilator in the Intensive Care Unit | March 2013 | June 2016 |
NCT01856010 | Completed | Study of Electroconvulsive Therapy (ECT) Treatment for Agitation and Aggression in Dementia | March 2011 | October 2012 | |
NCT01904760 | Completed | Phase 4 | Dexmedetomidine to Prevent Agitation After Free Flap Surgery | June 2013 | |
NCT01976754 | Completed | N/A | Safety Study of Dexmedetomidine in Septic Patients | September 2013 | July 2015 |
NCT02129348 | Completed | Phase 2 | Treatment of Psychosis and Agitation in Alzheimer's Disease | June 2014 | January 2020 |
NCT02194036 | Completed | N/A | Learning Oriented Physiotherapy - a New Approach | August 2014 | September 1, 2017 |
NCT02199262 | Completed | N/A | Quality Improving Program on Agitation in the Surgical Intensive Care Unit | February 2004 | January 2005 |
NCT02203019 | Completed | Phase 4 | Study of Sedative Medications in Patients With Severe Infection and Respiratory Failure | August 2014 | September 22, 2016 |
NCT02351882 | Completed | Phase 2/Phase 3 | Safety and Efficacy of Nabilone in Alzheimer's Disease | January 2015 | March 2019 |
NCT02428283 | Completed | Phase 4 | Scalp Nerve Block on Emergence Agitation | May 2015 | November 2016 |
NCT02525991 | Completed | Phase 4 | Phase IV to Evaluate the Safety of Self-administered ADASUVE® in Agitated Patients Outside the Hospital Setting | September 8, 2016 | December 31, 2019 |
NCT02720705 | Completed | Phase 2/Phase 3 | Transbucal Dexmedetomidine for Prevention of Sevoflurane Emergence Agitation in Pre-school Children | May 2016 | November 2018 |
NCT02848963 | Completed | Phase 4 | Comparison of Ketamine-propofol Combinations | July 2016 | February 2017 |
NCT02863081 | Completed | Helping Older Persons Emerge Stronger | July 2016 | July 1, 2017 | |
NCT03317067 | Completed | Phase 3 | Effects of Dexmedetomidine on Delirium Duration of Non-intubated ICU Patients (4D Trial) | December 21, 2017 | February 23, 2023 |
NCT03554915 | Completed | Ketamine Versus Midazolam for Prehospital Agitation | August 1, 2017 | September 24, 2018 | |
NCT03639558 | Completed | Phase 4 | TREC-Lebanon: A Trial for Rapid Tranquilisation for Agitated Patients in the Emergency Setting | August 28, 2018 | July 7, 2019 |
NCT03773874 | Completed | Assessment of Analgesia, Sedation, Physical Restraints and Delirium in Spanish Intensive Care Units | February 12, 2018 | March 11, 2018 | |
NCT04010305 | Completed | Phase 1 | Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia | May 22, 2019 | July 31, 2019 |
NCT04266340 | Completed | N/A | Different Premedication in Pediatric Patients | December 13, 2020 | December 1, 2021 |
NCT04268303 | Completed | Phase 3 | Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia | January 24, 2020 | May 6, 2020 |
NCT04722614 | Completed | N/A | Music and Essential Oil in Agitation | April 11, 2021 | July 20, 2022 |
NCT04908605 | Completed | Phase 4 | Emergence Agitation After Nasal Surgery: a Randomized Controlled Comparison Between Melatonin and Mirtazapine | June 15, 2021 | March 31, 2022 |
NCT05165914 | Completed | N/A | Midazolam Effect on Agitation Postnasal Surgery | May 27, 2021 | December 1, 2021 |
NCT05271552 | Completed | Phase 3 | Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II) | April 27, 2022 | April 21, 2023 |
NCT00351299 | Completed | Phase 2 | Randomized Controlled Trial of Dexmedetomidine for the Treatment of Intensive Care Unit (ICU) Delirium | January 2006 | October 2012 |
NCT00417482 | Completed | Phase 4 | Antipsychotic Discontinuation in Alzheimer's Disease | August 2004 | April 2011 |
NCT00457366 | Completed | Phase 4 | A Comparison Study of the Efficacy of Quetiapine and Haloperidol in Agitated Adults in Emergency Room | May 2006 | May 2009 |
NCT00505804 | Completed | Phase 2 | A Comparison of Dexmedetomidine and Haloperidol in Patients With Intensive Care Unit (ICU)-Associated Agitation and Delirium | January 2005 | November 2008 |
NCT00590499 | Completed | Agitation in Post Operative Neurosurgical Patients | July 2012 | March 2013 | |
NCT00790075 | Completed | Phase 4 | Liquid Risperidone in the Treatment of Acute Agitation in Psychiatrically Hospitalized Children | January 2003 | December 2004 |
NCT00797277 | Completed | Phase 3 | Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in Schizophrenia | July 2006 | June 2009 |
NCT00857727 | Completed | Phase 3 | Use of Dexmedetomidine to Reduce Emergence Delirium Incident in Children | August 2009 | December 2011 |
NCT00866645 | Completed | Phase 2/Phase 3 | A Study To Evaluate The Efficacy And Safety Of Intramuscular Levosulpiride In Patients With Agitation Of Schizophrenia | February 2009 | July 2010 |
NCT00898807 | Completed | Phase 3 | Citalopram for Agitation in Alzheimer's Disease | July 2009 | September 2013 |
NCT01021696 | Completed | Phase 2/Phase 3 | Pain in Patients With Dementia and Behavioural Disturbances | November 2009 | October 2010 |
NCT01119638 | Completed | Phase 4 | Escitalopram Treatment for BPSD in Alzheimer's Disease in Comparison to Risperidone | April 2008 | May 2010 |
NCT01217541 | Completed | N/A | Collaboration Between Department of Old Age Psychiatry and Nursing Homes | September 2010 | March 2012 |
NCT01280890 | Completed | N/A | Person- Centred Care Among Nursing Home Patients With Dementia | February 2011 | June 2012 |
NCT00009217 | Completed | Phase 4 | Treatment of Behavioral Symptoms in Alzheimer's Disease | January 1999 | December 2004 |
NCT01400113 | Completed | Phase 4 | Treating Acutely Agitated Patients With Asenapine Sublingual Tablets | April 2012 | December 2012 |
NCT01440114 | Completed | N/A | The Effect of Intravenous Fentanyl Prior the End of Surgery on Emergence Agitation in Paediatric Patients After General Anesthesia | March 2010 | July 2011 |
NCT01501123 | Completed | N/A | Pre-hospital Agitation and Sedation Trial: A Randomized Controlled Trial of Haloperidol Versus Midazolam for the Sedation of the Agitated Patient | November 2011 | December 2015 |
NCT06052254 | Not yet recruiting | Phase 2 | Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type | December 2023 | December 2024 |
NCT05974527 | Not yet recruiting | Phase 4 | Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department | September 1, 2023 | June 30, 2026 |
NCT05522647 | Not yet recruiting | Detection of Risk Behaviors: Pilot Observational Study With Bedridden and Agitated Patients. | September 1, 2022 | August 31, 2023 | |
NCT06140342 | Recruiting | A Music-Based Mobile App for People Living With Alzheimer's Disease and Related Dementias (ADRD) | August 1, 2023 | January 1, 2025 | |
NCT05644262 | Recruiting | Phase 2 | Life's End Benefits of Cannabidiol and Tetrahydrocannabinol | December 18, 2023 | December 2025 |
NCT06037629 | Recruiting | Premature Enhanced Automated Capture of Comfort Knowledge | February 1, 2023 | January 2024 | |
NCT05557409 | Recruiting | Phase 3 | A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation | September 6, 2022 | June 2025 |
NCT04516057 | Recruiting | Phase 3 | Nabilone for Agitation Blinded Intervention Trial | February 1, 2021 | October 2025 |
NCT05397639 | Recruiting | Phase 3 | Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type | November 1, 2022 | January 2025 |
NCT00315900 | Terminated | Phase 3 | Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia | May 1, 2006 | February 28, 2008 |
NCT05665088 | Terminated | Phase 3 | Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III) | December 14, 2022 | September 11, 2023 |
NCT00833300 | Terminated | N/A | Haloperidol vs Olanzapine for the Management of ICU Delirium | June 2008 | November 2011 |
NCT02846740 | Terminated | N/A | Cranial Electric Stimulation to Modify Suicide Risk Factors in Psychiatric Inpatients. | March 1, 2017 | January 22, 2018 |
NCT03044249 | Terminated | Phase 2 | A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression | May 4, 2017 | January 30, 2020 |
NCT05276830 | Terminated | Phase 2 | An Efficacy, and Safety Study Of BXCL501 For The Treatment Of Agitation Associated With Dementia | February 8, 2022 | April 1, 2022 |
NCT02164773 | Unknown status | Phase 4 | Addition of Magnesium Sulfate to Caudal to Prevent Postoperative Emergence Agitation. | October 2013 | August 2014 |
NCT02590744 | Unknown status | N/A | Effects of Preoperative Using of Eye Patches on Prevention of Emergence Agitation After Cataract Surgery | October 2015 | October 2017 |
NCT03398759 | Unknown status | N/A | Butorphanol Mitigate Emergence Agitation in Patients Undergoing Functional Endoscopic Sinus Surgery | February 1, 2018 | December 31, 2020 |
NCT02216396 | Unknown status | A Naturalistic Two-year Cohort Study of Agitation and Quality of Life in Care Homes | April 2014 | December 2016 | |
NCT04312893 | Unknown status | N/A | The Effectiveness of Acupuncture for Delirium in Critically Ill Patients | March 12, 2020 | May 30, 2022 |
NCT04950738 | Unknown status | N/A | The Effectiveness of Acupuncture for Complications in Critically Ill Patients | August 1, 2021 | September 30, 2022 |
NCT01374737 | Unknown status | Phase 4 | ED50 of Dexmedetomidine to Prevent Emergence Agitation in Children | June 2011 | February 2012 |
NCT02104297 | Unknown status | Phase 4 | Effect of Deksmedetomidine and Remifentanil in Extubation Agitation | April 2014 | June 2014 |
NCT05273671 | Unknown status | Phase 4 | Nalbuphine Versus Dexmedetomidine for Prevention of Emergence Agitation in Pediatrics | March 1, 2022 | June 2, 2022 |
NCT02877108 | Unknown status | Naturalistic Adasuve Clinical Trial Study | April 2016 | April 2017 | |
NCT04039269 | Unknown status | N/A | Long Term Memory Preoperative Preparation Reduce Post Operative Behavioral Change | December 2013 | May 2020 |
NCT00786318 | Withdrawn | Phase 4 | Ziprasidone vs Standard Therapy for Agitated Patients in the ED | September 2008 | July 2011 |
NCT02103881 | Withdrawn | Phase 4 | Ketamine Versus Haloperidol for Severe Agitation Outside the Hospital | April 2014 | June 2014 |
NCT05313386 | Withdrawn | Phase 2 | Study of BXCL501 In Agitation Associated With Delirium in ICU Patients | February 23, 2021 | February 21, 2022 |
NCT02118688 | Withdrawn | Phase 4 | Efficacy and Safety of Risperidone and Trazodone Monotherapy and Combination Therapy in Critically Ill Patients With Delirium | March 2011 | March 2016 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0000713